---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-014025"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:33:24.125871+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical FY23: continuing ops revenue $7.2M, net loss $0.41 EPS; exits ablation

## Summary
- Continuing ops revenue $7.2M FY (+136% YoY); Q4 $2.4M (+118% YoY).
- GAAP net loss continuing ops $11.9M, EPS -$0.41; prior year net income $28.8M.
- Discontinued ops loss $69.7M, including $16.4M held-for-sale loss and $21.9M restructuring.
- Cash, equivalents, marketable securities $29.4M at Dec 31, 2023.
- Company shifts focus to Medtronic left-heart access distribution; no further guidance.

## SEC filing metadata
- accession: 0001628280-24-014025
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014025/0001628280-24-014025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014025/afib-20240401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-014025
- JSON: https://secwatch.observer/filing/0001628280-24-014025.json
- Plain text: https://secwatch.observer/filing/0001628280-24-014025.txt

## Key facts
- Earnings Releases
  Acutus Medical, Inc. reported fiscal year ended December 31, 2023 results: net income Net loss on continuing operations on a GAAP basis was $11.9 million for the full year ended December 31, 2023 and net lo, EPS net loss per share was $0.41.
  - Period: fiscal year ended December 31, 2023
  - Net income: Net loss on continuing operations on a GAAP basis was $11.9 million for the full year ended December 31, 2023 and net lo
  - EPS: net loss per share was $0.41
  - Result: reported results
  source text: On April 1, 2024, the Company issued a press release announcing its financial results for the fiscal year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024014025/0001628280-24-014025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.